Human carcinogenic risk evaluation: An alternative approach to the two-year rodent bioassay

Toxicological Sciences

Volumn 80, Issue 2, 2004, Pages 225-229

  Cohen, Samuel M ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cell proliferation; DNA reactive; Estrogen; Immunosuppressive; Mechanism; Non genotoxic

Indexed keywords

BUTYLATED HYDROXYANISOLE; CARCINOGEN; DNA; ESTROGEN; IMMUNOSUPPRESSIVE AGENT; MELAMINE; SACCHARIN;

ARTICLE; BIOASSAY; BLADDER CANCER; CANCER RISK; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; DNA DAMAGE; DNA REPLICATION; ENDOCRINE TUMOR; GENE MUTATION; GENOTOXICITY; HUMAN; IN VITRO STUDY; KIDNEY CANCER; MOLECULAR MODEL; NONHUMAN; OVARY CANCER; RAT; RISK ASSESSMENT; STOMACH CANCER; TESTIS CANCER;

ANIMALS; CARCINOGENS; CELL PROLIFERATION; DNA; HUMANS; RISK ASSESSMENT; RODENTIA; SPECIES SPECIFICITY;

RODENTIA;

EID: 4344595785     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh159     Document Type: Article

References (6)

1. Box, G. E. P. (1979). Robustness in the strategy of scientific model building. In Robustness in Statistics (R. L. Launer and G. N. Wilkinson, Eds.), pp. 201-235. Academic Press, New York.
2. Cohen, S. M. (1998). Cell proliferation and carcinogenesis. Drug Metab. Rev. 30, 339-357.
3. Cohen, S. M., Purtilo, D. T., and Ellwein, L. B. (1991). Pivotal role of increased cell proliferation in human carcinogenesis. Modern Pathol. 4, 371-382.
4. Greenfield, R. E., Ellwein, L. B., and Cohen, S. M. (1984). A general probabilistic model of carcinogenesis: Analysis of experimental urinary bladder cancer. Carcinogenesis 5, 437-445.
5. Grice, H. C. (1988). Safety evaluation of butylated hydroxyanisole from the perspective of effects on forestomach and oesophageal squamous epithelium. Food Chem. Toxicol. 26, 717-723.
6. Sonich-Mullin, C., Fielder, R., Wiltse, J., Baetcke, K., Dempsey, J., Fenner-Crisp, P., Grant, D., Hartley, M., Knaap, A., Kroese, D., Mangelsdorf, I., Meek, E., Rice, J. M., and Younes, M. (2001). IPCS conceptual framework for evaluating a MOA for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34, 146-152.